Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1948 1
1951 16
1952 27
1953 19
1954 27
1955 41
1956 17
1957 23
1958 19
1959 12
1963 4
1964 11
1965 48
1966 86
1967 99
1968 112
1969 145
1970 160
1971 157
1972 179
1973 178
1974 166
1975 189
1976 231
1977 157
1978 198
1979 244
1980 185
1981 202
1982 207
1983 244
1984 213
1985 237
1986 247
1987 233
1988 226
1989 286
1990 258
1991 219
1992 253
1993 212
1994 245
1995 234
1996 265
1997 260
1998 278
1999 264
2000 298
2001 322
2002 340
2003 445
2004 440
2005 544
2006 616
2007 623
2008 700
2009 788
2010 872
2011 881
2012 965
2013 1034
2014 1112
2015 1124
2016 1211
2017 1352
2018 1428
2019 1547
2020 1694
2021 1548
2022 1643
2023 1420
2024 505

Text availability

Article attribute

Article type

Publication date

Search Results

27,623 results

Results by year

Filters applied: . Clear all
Page 1
Dose reduction of biologics in patients with plaque psoriasis: a review.
van Riel CAM, Michielsens CAJ, van Muijen ME, van der Schoot LS, van den Reek JMPA, de Jong EMGJ. van Riel CAM, et al. Front Pharmacol. 2024 Mar 28;15:1369805. doi: 10.3389/fphar.2024.1369805. eCollection 2024. Front Pharmacol. 2024. PMID: 38606178 Free PMC article. Review.
Dose reduction (DR) of first-generation biologics for plaque psoriasis (TNF-alpha inhibitors (i) and interleukin (IL)-12/23i) has been described in a previous scoping review. ...In conclusion, DR seems promising, but a research gap still exists in randomized, prospe …
Dose reduction (DR) of first-generation biologics for plaque psoriasis (TNF-alpha inhibitors (i) and interleukin (IL)-12/23i) has bee …
Deciphering the causal association and co-disease mechanisms between psoriasis and breast cancer.
Li X, Huang L, Yan Y, Rong Y, Chen X, Gao M, Huang J. Li X, et al. Front Immunol. 2024 Mar 28;15:1304888. doi: 10.3389/fimmu.2024.1304888. eCollection 2024. Front Immunol. 2024. PMID: 38605947 Free PMC article.
This study sought to elucidate the causal connection and shared underlying mechanisms between psoriasis and BC through bidirectional Mendelian randomization (MR) and bioinformatic approaches. ...CONCLUSION: The results suggest that psoriasis may increase the …
This study sought to elucidate the causal connection and shared underlying mechanisms between psoriasis and BC through bidirectional …
Allergic Phenotypes and Sarcopenia: Evidence from Observational Studies and Mendelian Randomization Analysis.
Tang Z, Zhou G, Xiao Y, Liu H, Chen X, Shen M. Tang Z, et al. Phenomics. 2023 Aug 21;4(1):46-50. doi: 10.1007/s43657-023-00110-4. eCollection 2024 Feb. Phenomics. 2023. PMID: 38605907
This study is to explore the association of allergic phenotypes including atopic dermatitis (AD), asthma, eosinophils count (EC), and sarcopenia. We conducted observational studies and mendelian randomization (MR) analysis based on UK Biobank (UKB), the China Health and Re …
This study is to explore the association of allergic phenotypes including atopic dermatitis (AD), asthma, eosinophils count (EC), and sarcop …
Causal association between air pollution and autoimmune diseases: a two-sample Mendelian randomization study.
Hu H, Yang X, Chen Q, Huang X, Cao X, Zhang X, Xu Y. Hu H, et al. Front Public Health. 2024 Mar 28;12:1333811. doi: 10.3389/fpubh.2024.1333811. eCollection 2024. Front Public Health. 2024. PMID: 38605869 Free PMC article.
BACKGROUND: In recent years, an increasing number of observational studies have reported the impact of air pollution on autoimmune diseases (ADs). However, no Mendelian randomization (MR) studies have been conducted to investigate the causal relationships. ...CONCLUSION: O …
BACKGROUND: In recent years, an increasing number of observational studies have reported the impact of air pollution on autoimmune diseases …
Cannabidiol exerts multitarget immunomodulatory effects on PBMCs from individuals with psoriasis vulgaris.
Pagano C, Ciaglia E, Coppola L, Lopardo V, Raimondo A, Giuseppe M, Lembo S, Laezza C, Bifulco M. Pagano C, et al. Front Immunol. 2024 Mar 27;15:1373435. doi: 10.3389/fimmu.2024.1373435. eCollection 2024. Front Immunol. 2024. PMID: 38601151 Free PMC article.
Our aim was to evaluate CBD immune-modulatory effects in peripheral blood mononuclear cells (PBMC) of psoriasis individuals with particular attention to both innate and adaptative immune arms. ...
Our aim was to evaluate CBD immune-modulatory effects in peripheral blood mononuclear cells (PBMC) of psoriasis individuals with part …
Nocebo effects in systemic therapies for adult plaque psoriasis: A systematic review and meta-analysis.
Ma B, Park YJ, Barber K, Mydlarski PR. Ma B, et al. Front Med (Lausanne). 2024 Mar 27;11:1373520. doi: 10.3389/fmed.2024.1373520. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38601115 Free PMC article.
Estimates were pooled using a random effects model, and heterogeneity was evaluated using the I(2) statistic. ...No statistically significant RD in serious AEs or AEs leading to discontinuation was identified between systemic therapy and placebo groups. DISCUSSION: Half of …
Estimates were pooled using a random effects model, and heterogeneity was evaluated using the I(2) statistic. ...No statistically sig …
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy.
Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Chen ST, et al. J Immunother Cancer. 2024 Apr 10;12(4):e007675. doi: 10.1136/jitc-2023-007675. J Immunother Cancer. 2024. PMID: 38599660 Free article.
Consensus definitions were achieved for 10 core D-irAE diagnoses: ICI-vitiligo, ICI-lichen planus, ICI-psoriasis, ICI-exanthem, ICI-bullous pemphigoid, ICI-Grover's, ICI-eczematous, ICI-eruptive atypical squamous proliferation, ICI-pruritus without rash, and ICI-erosive mu …
Consensus definitions were achieved for 10 core D-irAE diagnoses: ICI-vitiligo, ICI-lichen planus, ICI-psoriasis, ICI-exanthem, ICI-b …
Identification of pyruvic and maleic acid as potential markers for disease activity and prognosis in chronic urticaria.
Jian X, Hou G, Li L, Diao Z, Wu Y, Wang J, Xie L, Peng C, Lin L, Li J. Jian X, et al. J Allergy Clin Immunol. 2024 Apr 8:S0091-6749(24)00336-1. doi: 10.1016/j.jaci.2024.01.032. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 38599289
Meanwhile, differential metabolites N6-acetyl-l-lysine, L-aspartate, maleic acid and pyruvic acid were used to respectively construct random forest classifiers, and achieved AUCs greater than 0.85, suggesting their potential as diagnostic biomarkers of CU. ...
Meanwhile, differential metabolites N6-acetyl-l-lysine, L-aspartate, maleic acid and pyruvic acid were used to respectively construct ran
Guselkumab for Pityriasis Rubra Pilaris and Dysregulation of IL-23/IL-17 and NFkB Signaling: A Nonrandomized Trial.
Velasco RC, Shao C, Cutler B, Strunck J, Kent G, Cassidy PB, Choate K, Greiling TM. Velasco RC, et al. JAMA Dermatol. 2024 Apr 10:e240257. doi: 10.1001/jamadermatol.2024.0257. Online ahead of print. JAMA Dermatol. 2024. PMID: 38598229
Subcutaneous injections were given at the US Food and Drug Administration-approved dosing schedule for psoriasis over a 24-week period. MAIN OUTCOMES AND MEASURES: The primary outcome was the mean change in the Psoriasis Area Severity Index (PASI) score at week 24. …
Subcutaneous injections were given at the US Food and Drug Administration-approved dosing schedule for psoriasis over a 24-week perio …
Understanding preferences for receiving health communications and information about clinical trials: a cross-sectional study among US adults.
Majumdar D, Webb D, Parsons S, Selwan-Lewis EM, Rettig T, Chastain E, Obanor W, Birnberg R, Kuang A. Majumdar D, et al. Curr Med Res Opin. 2024 Apr 10:1-13. doi: 10.1080/03007995.2024.2340720. Online ahead of print. Curr Med Res Opin. 2024. PMID: 38595182
This cross-sectional study explored participants' understanding of their health condition, their preferences for receiving health communications, and their interest in receiving clinical trial results across several therapeutic areas. METHODS: The study recruited pa …
This cross-sectional study explored participants' understanding of their health condition, their preferences for receiving health communicat …
27,623 results
You have reached the last available page of results. Please see the User Guide for more information.